Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.

The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

Professor Thumbi Ndung'u and his team at the Africa Health Research Institute are pioneering a study that explores innovative ...

Professor Thumbi Ndung'u and his team at the Africa Health Research Institute are pioneering a study that explores innovative ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...

The study found 20% of women who took a drug intervention that included antibodies remained virally suppressed without ...

Advanced HIV Disease is when a person living with HIV has a CD4 cell count of below 200 cells. CD4 cells are white blood ...

The University of KwaZulu-Natal (UKZN) is set to host a crucial engagement session on Friday, April 5, focusing on a ...

Zimbabwe has secured an additional three-month supply of antiretroviral (ARV) drugs to ensure uninterrupted treatment for ...

As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the ...

The recent US funding cuts have created critical gaps in the HIV response across East and Southern Africa. The gaps, unless filled, will have severe public health consequences, reversing the gains ...

Only 59% of those in need have access to treatment, and about one in four people living with HIV are unaware of their status. Additionally, individuals on ART who adhere to uninterrupted treatment ...